1.Combination of TIPSS and azygoportal disconnection for portal hypertension
Jianmin CAO ; Xingjiang WU ; Jianming HAN
Journal of Interventional Radiology 1994;0(02):-
Objective To investigate the clinical results of combined TIPSS and azygoportal disconnection for portal hypertension in controlling and preventing esophageal variceal bleeding. Methods From Oct. 1996 to Dec. 2001, 60 patients with portal hypertension were admitted to our department because of variceal bleeding and submitted to the treatment with the combination TIPSS and azygoportal disconnection. According to Child Pugh classification, 11 patients were in class A, 37 in class B, and 12 in class C. 41 patients showed mild ascites and 8 with severe ascites. The mild and severe esophageal varices were proven by upper digestive barium meal. The procedure was divided into two stages; first, TIPSS procedure with the stent of diameter 0.8cm and length 6-7cm was successfully inplanted in all patients, second, all patients underwent azygoportal disconnection two weeks later after TIPSS. Results After the combination TIPSS and azygoportal disconnection, the recent complications included three cases with bleeding at operative fields, one case with infradiaphagmatic abscess and seven with slight encephalopathy. No rebleeding of esophageal varices and death occurred during the treatment. During the follow up of 1-5 years, the rates of shunt occlusion, rebleeding and death were 11.9%, 3.5% and 7.0% respectively. Conclusions The combination TIPSS and azygoportal disconnection is an efficient therapeutic methods for portal hypertension.
2.Effects of somatostatin and octreotide on portal pressure in portal hypertensive patients undergoing TIPS procedure
Jianfen YANG ; Xingjiang WU ; Jianmin CAO ; Jianming HAN ; Jieshou LI
Chinese Journal of General Surgery 2001;0(10):-
Objectives The purpose of this study was to compare the effect of somatostatin and octreotide on portal vein pressure in portal hypertensive patients.KG*2MethodsWT5”BZ Portal pressure in 12 patients with portal hypertension after TIPS was measured directly by means of a cathater placed in portal vein after infusion of somatostatin (6 mg/24h) or octreotide(0 6 mg/h). The drugs was infused intravenously and alternatively in each individual patient on day 1 or day 3 after TIPS. Portal pressure was assessed at baseline and at 1、2、4、6、8、12、24、30、36 hours after infusion of each drug.KG*2ResultsKG1The average decrease of portal pressure was 9 4?1 0 cm H 2 O and 5 0?1 0 cm H 2 O respectively after the intravenous infusion of somatostatin or octreotide( P
3.Effects of Somatostatin-14 and-8 on portal hemodynamics in patients with portal hypertension after intrahepatic portosystemic shunt
Jianfen YANG ; Xingjiang WU ; Jieshou LI ; Jianmin CAO ; Jianming HAN
Journal of Medical Postgraduates 2003;0(11):-
Objective:To study the effects of Somatostatin-14 and-8 on portal hemodynamics and plasma levels of the insulin-like growth factor(IGF-1),nitric oxide(NO),endothelin-1(ET-1) and glucagon(GLU) in patients with portal hypertension after transjugular intrahepatic portosystemic shunt(TIPS). Methods:Fourteen portal hypertension patients underwent TIPS,their portal pressures directly measured by the intravenous catheter placed in the portal vein,the hemodynamic changes observed and the plasma levels of IGF-1,NO,ET-1 and GLU determined before and 8 and 24 hours after the infusion of Somatostatin-14 or-8 according to a cross-over design.Results:The average decrease in portal pressure after the intravenous infusion of Somatostatin-14 and-8 was(9.4?1.0) cmH2O and(5.0?1.0) cmH2O,respectively(P0.05) 8 and 24 hours after the infusion.Conclusion:Both Somatostatin-14 and-8 can significantly reduce portal pressure,although the former is more potent than the latter.The underlying mechanism may involve their inhibition of the secretion of GLU,IGF-1 and other hormones as well as their reduction of hepatic metabolism and portal inflow.
4.Effects of ePTFE-covered stents versus bare stents on portal hemodynamics in patients of transjugular intrahepatic portosystemic shunts
Qian HUANG ; Xingjiang WU ; Xinxin FAN ; Lin XU ; Jianmin CAO ; Jieshou LI
Chinese Journal of General Surgery 2010;25(5):393-397
Objective To study the effects of ePTFE-covered stents versus bare stents on portal hemodynamics in portal hypertensive patients receiving TIPS. Methods Sixty patients with portal hypertension underwent TIPS with 8 mm diameter bare stents and ePTFE-covered stent from April 2007 to April 2009. The clinical outcomes were observed after TIPS, and the hemodynamics of potal vein system were studied before and after TIPS and during the follow up using direct portography and color Doppler ultrasound technique. Results TIPS procedures were successful in all patients without major complications. The follow-up of patients with bare stents were (8 ± 4) months and follow-up of ePTFEcovered stents group were (6 ± 4) months. Immediately after the TIPS the portosystemic pressure gradient of the two groups decreased by 60% and 58%, respectively(t =0.79, P >0.05). During the follow-up,portosystemic pressure gradient of bare stents group increased gradually, while that in ePTFE-covered stents group maintained low portosystemic pressure gradient (13.2 ± 1.2) mm Hg vs. (9. 5 ± 2. 9) mm Hg, P =0. 015. The blood velocity and volume of venous return of potal vein system were significantly higher in ePTFE-covered stents group than in bare stents group during the follow-up using color Doppler ultrasound method. The blood velocity and volume of the shunts were significantly higher in covered stents group than in bare stents group after 1 year, (125 ±20) cm/s vs. (88 ±13) cm/s, and (1816 ±380) ml/min vs.(1074 ±239) ml/min, respectively P<0. 01. Conclusions In TIPS patients with ePTFE-covered stents high blood velocity and low portosystemic pressure gradient sustained in contrast with those using bare stents.
5.Verification of positioning accuracy of MLC leaves of 8 medical accelerators in IMRT in Jiangsu province
Chunyong YANG ; Xingjiang CAO ; Yuanyuan ZHOU ; Yimei ZHANG ; Jin WANG
Chinese Journal of Radiological Medicine and Protection 2019;39(2):128-131
Objective To measure the accuracy of multi-leaves collimator (MLC) leaves positions in intensity modulated radiation therapy (IMRT) for verification purpose.Methods Solid water homogeneous phantom with size of 30 cm× 30 cm was scanned by CT scanner.The scanned images were delivered to radiation therapy plan system (TPS) to formulate the therapy plan.The MLC leaves created 5 strips of exposure field,each 3 cm long and 0.6 cm wide.The strip-to-strip distance was 3 cm.With 6 MV X-rays,the SSD was 100 cm at the maximum dose point.The MU per strip was 250 MU.EBT2 radiochromic films each of 25 cm×25 cm were placed on the 30 cm×30 cm homogeneous solid phantom and covered with 1 cm thick solid phantom slabs for delivering of IMRT.Results For 7 of 8 accelerators,the differences of film-measured and TPS-planned MLC leaf position for every fence field were within ± 0.5 mm as required by IAEA,with only other one being-0.6 mm,not consistent with the IAEA requirements.The film-measured position difference between each pair and all pairs of leaves for 8 accelerators were all in line with IAEA's requirements.The film-measured actual width difference between each pair and all pairs of leaves was within ±0.75 mm as required by IAEA for 4 accelerators and outside ±0.75 mm for the other three,not consistent with the IAEA requirements.The standard deviation of film-measured actual width between each pair and all pairs of leaves for 6 accelerators were ≤ 0.3 mm,as required by IAEA,whereas >0.3 mm for the other two,not consistent with IAEA requirements.Conclusions The film dosimetric verification of IMRT is an important part of its quality assurance,featuring simple,reliable and highly accurate positioning and can meet measurement requirement.
6.Assessment of Specification for testing of quality control in γ-ray sources afterloading brachytherapy (WS 262-2017) in Jiangsu Province, China
Xiangyong FAN ; Wei CHEN ; Xingjiang CAO ; Jin WANG
Chinese Journal of Radiological Health 2024;33(3):299-303
Objective To evaluate the implementation, application, problems, and suggestions associated with the WS 262-2017 Specification for Testing of Quality Control in γ-Ray Sources Afterloading Brachytherapy among radiation workers in Jiangsu Province, China, and to provide a scientific basis for further revision and implementation of this standard. Methods A questionnaire survey was conducted among employees of public and private institutions involved in radiation health technology services, radiation health supervision, and medical services in Jiangsu Province who carried out afterloading testing, supervision, and treatment. The survey primarily focused on the implementation status, technical content, and implementation effect of WS 262-2017, and the results were summarized and analyzed. Results A total of 185 valid questionnaires were collected, and 73.5% of the respondents were aware of the standard. Among the respondents who were aware of the standard, 29.4% did not participate in relevant training, and 41.2% did not use or infrequently used the standard. Moreover, 94.1% of survey respondents considered the standard to be scientifically robust and free of issues, 88.6% responded that the main technical content of the standard was highly operable, and 97.8% agreed that the main content of the standard was coordinated and consistent with relevant regulatory standards. In addition, 88.6%, 90.8%, and 87.0% of survey respondents reported that this standard provided significant assistance and played an important role in optimizing radiation protection, quality control and testing of radiation therapy equipment, and improving professional skills for technical personnel. Conclusion Radiation workers in Jiangsu Province have a high awareness rate of WS 262-2017 and believe that this standard is scientifically rigorous and plays an important role. There is no need for revision, but relevant departments should strengthen the promotion and training concerning the standard.
7. Verification of doses to PTV and OAR and 2D dose distribution in IMRT for 8 accelerators in Jiangsu province
Chunyong YANG ; Yuanyuan ZHOU ; Xingjiang CAO ; Xiang DU ; Suming LUO ; Xian XUE ; Zhijian HE ; Jin WANG
Chinese Journal of Radiological Medicine and Protection 2020;40(2):129-133
Objective:
To validate the method for measuring the TPV and OAR doses and 2D dose distribution in IMRT through using TLD and radiochromic film.
Methods:
Eight medical linear accelerators (Valian, Elekta, Siemens) were selected. The polystyrene phantom provided by IAEA was CT scanned and the image obtained was transferred to TPS for formulation of treatment plan, prescription of PTV and OAR doses and calculation of corresponding monitoring unit (MU), IMRT was performed on the phantom using 6 MV X-ray. Irradiated TLDs and films were measured and evaluated at the Secondary Standard Dosimetry Laboratory at the Radiation Safety Institute of Chinese Center for Disease Control and Prevention.
Results:
According to IAEA requirement, the relative deviations between TLD-measured and TPS-planned doses were within ±7.0% for the prescribed PTV and OAR doses. As measured result, the PTV values for 8 accelerators were in the range of 0.6% to 5.9%, consistent with the IAEA requirements, whereas the OAT values for 8 accelerators were within -0.6% to 7.0%, consistent the requirements. As IAEA required, the 2D dose distribution passing rate of 3 mm/3% should be higher than 90%. The film-measured and TPS-planned values for 8 accelerators were within 90.2% to 100.0%, consistent with the requirements.
Conclusions
TLD and radiochromic film are feasible in validating the PTV and OAR doses and the 2D dose distribution pass rate in IMRT. This method can be widely used in quality audit and internal verification in IMRT in medical institutiions on a large scale.